schedule 1

A new player is entering the psychedelics production space. Small molecule therapeutic contract developer Societal CDMO Inc. (NASDAQ: SCTL) has secured a DEA Schedule 1 Controlled Substances manufacturer’s license and is entering the biopharma industry’s psychedelic drugs subsection....

The federal government’s current position on cannabis and its stranglehold as a harmful Schedule 1 drug, which makes it ineligible for rigorous medical examination, is hampering vital research on the plant and harming millions of Americans, including veterans. Federal research of...